The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price increase of 60.43%. However, over the past six months, we’ve seen a weaker performance of 43.87%. The price of ORGO fallen by 47.19% over the last 30 days. And in the last five days, it has surged by 17.99%.
The market performance of Organogenesis Holdings Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $6.71 on 03/03/25, while the lowest value for the same duration was $2.28 on 08/12/24.
52-week price history of ORGO Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Organogenesis Holdings Inc’s current trading price is -33.53% away from its 52-week high, while its distance from the 52-week low is 95.61%. The stock’s price range during this period has varied between$2.28 and $6.71. The Organogenesis Holdings Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.74 million for the day, a figure considerably lower than their average daily volume of 1.42 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Organogenesis Holdings Inc (ORGO) has experienced a quarterly rise of 14.65% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 565.76M and boasts a workforce of 869 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
ORGO’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ORGO stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.09.
